Literature DB >> 19623572

Relationship between psychopathy and indirect aggression use in a noncriminal population.

Gemma C Warren1, Jane Clarbour.   

Abstract

Psychopathy has long been associated with increased use of direct aggression and violence, especially among male inmates. Little research has, of yet, considered the relation between psychopathy and indirect forms of aggression. The current research sought to investigate the relationship between psychopathy and indirect aggression in a noncriminal sample. The results indicated that there was a strong relationship between psychopathic traits and indirect aggression, with strong correlations between indirect aggression and both factor 1 (coldheartedness) and factor 3 (impulsive antisociality). This association remained significant even after the effects of direct aggression had been controlled for. Path analysis indicated that both direct and indirect aggression was underpinned by the same psychopathy factors. This suggests that high psychopathy scorers will utilize direct and indirect aggression equally and, as such, the choice of one type of aggression over the other may be dependant on either situational factors or external moderators.

Entities:  

Mesh:

Year:  2009        PMID: 19623572     DOI: 10.1002/ab.20317

Source DB:  PubMed          Journal:  Aggress Behav        ISSN: 0096-140X            Impact factor:   2.917


  3 in total

Review 1.  Psychopathy and aggression: when paralimbic dysfunction leads to violence.

Authors:  Nathaniel E Anderson; Kent A Kiehl
Journal:  Curr Top Behav Neurosci       Date:  2014

2.  Sex differences on the four-facet model of psychopathy predict physical, verbal, and indirect aggression.

Authors:  Nicholas D Thomson; Kiril Bozgunov; Elena Psederska; Jasmin Vassileva
Journal:  Aggress Behav       Date:  2019-01-30       Impact factor: 3.047

3.  Consideration of future consequences (CFC) serves as a buffer against aggression related to psychopathy.

Authors:  Yongping Zhao; Jia Wei; Yuanshu Chen; Lingxiang Xia
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.